User:Mr. Ibrahem/Suvorexant

Suvorexant, sold under the trade name Belsomra, is a medication used to treat trouble sleeping, including trouble falling asleep and staying asleep. It may be effective for at least a year. It is taken by mouth, half an hour before bed.

Common side effects include sleepiness, headache, unusual dreams, cough, and dry mouth. Other side effects include abuse, sleep paralysis, suicide, anxiety, and a decreased ability to drive. Safety in pregnancy and breastfeeding is unclear. It is a dual orexin receptor antagonist (DORA).

Suvorexant was approved for medical use in the United States in 2014, and Canada in 2018. In the United States it costs about 380 USD per month as of 2021. In the United States it is a Schedule IV controlled substance.